NeoGenomics (NEO) Earnings Analysis
NeoGenomics (NEO) has no confirmed upcoming earnings date. Last quarter (2026-02-17) it beat with EPS 0.06 USD vs 0.04 USD est (+50%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E -3.65.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does NEO next report earnings?
No confirmed upcoming earnings date is currently scheduled for NEO. This page updates as the calendar is published.
NEO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-17 | 0.06 USD | 0.04 USD | +50% | Beat |
| 2025-02-18 | 0.04 USD | 0.03 USD | +33.3% | Beat |
| 2024-07-29 | 0.03 USD | 0.00306 USD | +880.4% | Beat |
Beat rate: 3/3 (100%) over reported quarters with consensus data.
NEO valuation and analyst view
| Trailing P/E | -3.65 |
|---|---|
| Trailing EPS | -3.84033 USD |
| Price / book | 0.44 |
| Dividend yield | 0.00% |
| Market cap | 0.36B |
| Analyst consensus | Buy (23 buy / 5 hold / 1 sell) |
| Avg price target | 25 USD |
Related research pages
Frequently asked questions
When is NeoGenomics (NEO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for NEO. This page updates as the calendar is published.
Did NEO beat earnings last quarter?
In its 2026-02-17 report, NEO posted EPS of 0.06 USD versus a 0.04 USD estimate — a beat of 50%.
What is NEO's earnings track record?
Over the last 3 reported quarters with consensus data, NEO beat estimates 3 times (100%).
What is NEO's current P/E ratio and EPS?
NEO trades at a trailing P/E of -3.65 on trailing EPS of -3.840329498474831 USD.
What do analysts rate NEO?
Analyst consensus is "Buy" across 29 ratings (1 strong buy, 22 buy, 5 hold, 1 sell, 0 strong sell). Average 12-month price target: 25 USD.